跖跗关节融合治疗隐匿性Lisfranc损伤  

Tarsometatarsal fusion for treatment of hidden Lisfranc injury

作　　者：王哲天 曾林如 庄新凯 常轶铁 李妍[1] WANG Zhe-tian;ZENG Lin-ru;ZHUANG Xin-kai;CHANG Yi-tie;LI Yan(Jiangnan Hospital,Zhejiang University of Chinese Medicine,Hangzhou,Zhejiang 311201,China)

机构地区：[1]浙江中医药大学附属江南医院,浙江杭州311201

出　　处：《中国矫形外科杂志》2025年第4期361-364,共4页Orthopedic Journal of China

摘　　要：[目的]探讨跖跗关节融合术治疗隐匿性Lisfranc损伤的临床疗效分析。[方法]回顾性研究2010年4月—2020年5月19例隐匿性Lisfranc损伤患者的临床资料,均行跖跗关节融合术。分析临床和影像资料。[结果]患者均顺利完成手术,无神经、血管损伤等并发症,随访时间12~24个月。随时间推移,VAS评分显著减少[(5.2±1.6),(1.5±0.8),(1.1±0.7),P<0.001],而AOFAS评分[(48.5±5.2),(75.8±8.7),(80.8±6.7),P<0.001]和SF-36评分[(40.1±5.9),(70.7±4.0),(75.4±6.3),P<0.001]显著增加。影像方面,随时间推移,患足非负重位X线片C1-M2的间隙[(3.6±1.4),(1.2±0.2),(1.0±0.3),P<0.001]和M1-M2的间隙[(4.6±1.1),(1.6±0.3),(1.4±0.4),P<0.001]显著减少。[结论]跖跗关节融合术是治疗隐匿性Lisfranc损伤的安全、有效的术式。[Objective]To investigate the clinical outcome of tarsometatarsal fusion in the treatment of hidden Lisfranc injury.[Methods]A retrospective study was conducted on 19 patients who had hidden Lisfranc injury treated by tarsometatarsal fusion in our hospital from April 2010 to May 2020.The clinical and imaging data were analyzed.[Results]All the patients had operation performed successfully without neurovascular injury and other complications,and followed up from 12 months to 24 months.The VAS score significantly reduced[(5.2±1.6),(1.5±0.8),(1.1±0.7),P<0.001],while the AOFAS score[(48.5±5.2),(75.8±8.7),(80.8±6.7),P<0.001],SF-36 score[(40.1±5.9),(70.7±4.0),(75.4±6.3),P<0.001]increased significantly over time.In terms of image,the clearance between the cuniform 1 and metatarsal 2(C1-M2)in X ray of non weight bearing position[(3.6±1.4),(1.2±0.2),(1.0±0.3),P<0.001]and the clearance of M1-M2[(4.6±1.1),(1.6±0.3),(1.4±0.4),P<0.001]significantly reduced with time.[Conclusion]Tarsometatarsal fusion is a safe and effective operation for hidden Lisfranc injury,

关 键 词：LISFRANC损伤 跖跗关节 桥接钢板 关节融合 

分 类 号：R683.42[医药卫生—骨科学]